NDC 51655-628
Naproxen Delayed Release
Naproxen Delayed Release
Naproxen Delayed Release is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Northwind Pharmaceuticals. The primary component is Naproxen.
| Product ID | 51655-628_bf547f77-f9d8-475d-8bf5-4ec40b616b0f |
| NDC | 51655-628 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Naproxen Delayed Release |
| Generic Name | Naproxen Delayed Release |
| Dosage Form | Tablet, Delayed Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2014-05-16 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA091432 |
| Labeler Name | Northwind Pharmaceuticals |
| Substance Name | NAPROXEN |
| Active Ingredient Strength | 500 mg/1 |
| Pharm Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |